Centaurus Financial Inc. Sells 1,044 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Centaurus Financial Inc. trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,311 shares of the company’s stock after selling 1,044 shares during the quarter. Centaurus Financial Inc.’s holdings in GE HealthCare Technologies were worth $1,184,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in GEHC. Teachers Retirement System of The State of Kentucky increased its position in GE HealthCare Technologies by 258.7% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 124,787 shares of the company’s stock worth $9,649,000 after purchasing an additional 90,000 shares during the period. Chicago Partners Investment Group LLC increased its position in GE HealthCare Technologies by 14.6% in the fourth quarter. Chicago Partners Investment Group LLC now owns 4,241 shares of the company’s stock worth $303,000 after purchasing an additional 539 shares during the period. Scarborough Advisors LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter worth about $82,000. WNY Asset Management LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter worth about $205,000. Finally, Voisard Asset Management Group Inc. acquired a new stake in GE HealthCare Technologies in the fourth quarter worth about $93,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Down 0.6 %

NASDAQ GEHC traded down $0.50 during trading on Friday, hitting $76.49. The stock had a trading volume of 2,576,779 shares, compared to its average volume of 2,285,386. The company has a market capitalization of $34.91 billion, a PE ratio of 22.37, a P/E/G ratio of 2.75 and a beta of 1.22. The company’s 50-day moving average price is $81.37 and its two-hundred day moving average price is $81.13. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.83 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter in the prior year, the business posted $0.85 EPS. The business’s revenue was down 1.2% compared to the same quarter last year. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date of this dividend was Thursday, April 18th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Insider Buying and Selling

In related news, CEO Jan Makela sold 20,227 shares of the business’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $81.57, for a total transaction of $1,649,916.39. Following the transaction, the chief executive officer now directly owns 63,348 shares of the company’s stock, valued at approximately $5,167,296.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other GE HealthCare Technologies news, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the transaction, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jan Makela sold 20,227 shares of the company’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $81.57, for a total value of $1,649,916.39. Following the completion of the transaction, the chief executive officer now directly owns 63,348 shares in the company, valued at $5,167,296.36. The disclosure for this sale can be found here. In the last three months, insiders have sold 90,482 shares of company stock valued at $7,369,137. 0.27% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages recently commented on GEHC. Bank of America lowered their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Citigroup boosted their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Argus boosted their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 target price for the company. Finally, Evercore ISI boosted their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.